By Michael Bloom
Publication Date: 2026-02-14 13:50:00
Goldman Sachs revealed a slew of stocks that the firm says are extremely compelling. The Wall Street investment bank said companies including Nvidia have plenty of upside amid the market volatility. Other buy-rated names screened by CNBC Pro include: Teva, Philip Morris, S & P Global and Apollo. Teva Teva’s stock has doubled over the past year, but fears that it’s come too far, too fast are overdone, according to Goldman Sachs. Analyst Matt Dellatorre and team says the pharma stock is extremely attractive at current levels and that investors should remain calm. “While we appreciate this concern from a risk-reward perspective we highlight that the outlook for the company today is now fundamentally different from what it was just a few years ago — and thus comparisons to historical multiples are increasingly less relevant,” he wrote. Shareholders should continue to accumulate shares as Teva is on a rapidly ascending earnings trajectory with a robust pipeline, the analyst said. Dellatorre also raised his price target to $45 per share from $36. Shares of the company are up more than 8% so far this year. Philip Morris The tobacco giant is also firing on cylinders. Analyst Bonnie Herzog and team said in a recent note that the shares have plenty of upside. “PM is transforming into a faster growing and more profitable business — an earnings compounder with an attractive valuation,” she wrote. Goldman also said it likes management’s aggressive 2026 outlook. “To put it simply,…